Compare AbCellera Biologics Inc (ABCL) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Verizon Communications Inc — how do they compare? AbCellera Biologics Inc trades at $9.2 (market cap $2.99B), while Verizon Communications Inc trades at $47.14 (market cap $196.40B). The key difference: Verizon Communications Inc is far larger — about 65.7× AbCellera Biologics Inc's market cap, and Verizon Communications Inc pays a 5.99% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | VZ | |
|---|---|---|
Market Cap | $2.99B | $196.40B |
Sector | Health | Media |
52-Week High | $9.76 | $51.38 |
52-Week Low | $2.78 | $38.40 |
Enterprise Value | $2.58B | $383.10B |
Volume | — | 22,584,735 |
Dividend Yield | — | 5.99% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
